This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Newsletter Archive
GU Onc Daily
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
Integrating Genomic Testing with MRI Enhances Stratification of Surveillance Patients
Sent on 23 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 23 January 2025
Receive via e-mail
Breakthroughs in Targeted Treatments in Urothelial Cancers
Sent on 22 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 22 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 21 January 2025
Receive via e-mail
Innovations in Staging, Imaging, and Treatments In Advanced Prostate Cancer
Sent on 20 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 20 January 2025
Receive via e-mail
Advancing Bladder Cancer Treatments: Evaluating Immunotherapy, Combination Strategies, and Targeted Treatments
Sent on 17 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 17 January 2025
Receive via e-mail
Navigating the Complexities of Bladder Cancer: Non-Invasive Diagnostics and Surveillance
Sent on 16 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 16 January 2025
Receive via e-mail
Transformative Clinical Trial Data in Metastatic Prostate Cancer
Sent on 15 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 15 January 2025
Receive via e-mail
Genomic Insights Inform Prostate Cancer Progression
Sent on 14 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 14 January 2025
Receive via e-mail
Something Old, Something New, Something Borrowed - Treatment Development For Advanced Prostate Cancer
Sent on 13 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 13 January 2025
Receive via e-mail
Advancing Imaging Techniques for Small Renal Mass Diagnosis and Clinical Decision-Making
Sent on 11 January 2025
Receive via e-mail
Who is The Right Patient for Lutetium-177 PSMA Treatment?
Sent on 10 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 10 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 09 January 2025
Receive via e-mail
Managing BCG Shortages and Advancing Bladder Cancer Care
Sent on 08 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 08 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 07 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 06 January 2025
Receive via e-mail
Prostate Cancer Innovations & Practice Management Solutions: Highlighting the 2024 LUGPA Annual Meeting
Sent on 05 January 2025
Receive via e-mail
Multidisciplinary Approaches in Advanced Prostate Cancer Care
Sent on 04 January 2025
Receive via e-mail
Predicting Response to Bipolar Androgen Therapy (BAT) - A Blood-Based Biomarker Approach
Sent on 03 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 03 January 2025
Receive via e-mail
Paradigm Shifts that Elevated Care in 2024: Looking Ahead into 2025
Sent on 02 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 02 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 01 January 2025
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 31 December 2024
Receive via e-mail
Paradigm Shifts that Elevated Care in 2024: Case-Based: Navigating Patient Care
Sent on 30 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 30 December 2024
Receive via e-mail
Paradigm Shifts that Elevated Care in 2024: Best of GU Conferences
Sent on 28 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 27 December 2024
Receive via e-mail
Paradigm Shifts that Elevated GU Care in 2024: Key Breakthroughs of the Year
Sent on 26 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 26 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 25 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 24 December 2024
Receive via e-mail
2024's GU Oncology Advances: Going Beyond the Abstracts
Sent on 23 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 23 December 2024
Receive via e-mail
International Bladder Cancer Group Quarterly Newsletter: Volume 3
Sent on 21 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 20 December 2024
Receive via e-mail
Managing BCG-Unresponsive NMIBC: Treatment Strategies, Progression, and Emerging Therapies
Sent on 19 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 19 December 2024
Receive via e-mail
Value-Based Care and Reducing Prescription Drug Costs
Sent on 18 December 2024
Receive via e-mail
UroAlert - GU Oncology Daily
Sent on 18 December 2024
Receive via e-mail
Integrating Genetic Variants and Clinical Factors for Improved Prostate Cancer Prognostication
Sent on 17 December 2024
Receive via e-mail
Page
of 102
Display #
5
10
15
20
25
30
50
100
Results 1 - 50 out of 5071
Send the selected Newsletters to...
Name
E-mail
Send
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free